Tony Huge

19-Nor Steroids Explained: Nandrolone, Trenbolone, and Why They Break the Rules

Table of Contents

I’ve had my bloodwork pulled and read back to me for 14 years now, and the panel I watch closest was never testosterone. It’s prolactin. Most guys never order it. The 19-nor class is the reason I do.

TL;DR

  • A 19-nor steroid is testosterone with the carbon-19 methyl group removed. That one change is why nandrolone and trenbolone barely aromatize, and why nandrolone picks up real activity at the progesterone receptor that testosterone doesn’t have.
  • Nandrolone is Schedule III and prescription-only in the US. Trenbolone has never been approved for human use anywhere; it exists as a cattle implant.
  • The progesterone activity, not estrogen, is the mechanism behind “deca dick.” It runs through prolactin and dopamine, and it can show up even when your estradiol and total testosterone both look fine on paper.
  • Recovery lags testosterone-only cycles because the progestogenic suppression stacks on top of the androgenic suppression. Law 4 again: the harder you push a self-regulating system, the harder it pushes back, and here it pushes back on 2 fronts at once.
  • Trenbolone has zero human clinical trials behind it. Every number people quote about it in humans comes from cattle studies, cell assays, and forum bloodwork.

What Makes a Steroid “19-Nor” in the First Place

Testosterone is a 19-carbon steroid. Carbon 19 is a methyl group on the backbone, and the body needs it gone before aromatase can turn a molecule into estrogen. Take that methyl group off and you get a 19-nor steroid: nandrolone, trenbolone, and a handful of others (norethisterone, the progestin in some birth control, shares the same core structure).

That missing carbon changes 2 things at once. First, aromatization: nandrolone is a poor substrate for human aromatase and converts to estrogen at a small fraction of testosterone’s rate, and trenbolone barely aromatizes at all. Second, 5-alpha reduction runs backward. Testosterone gets reduced into DHT, which binds the androgen receptor harder, driving prostate growth and hair loss efficiently. Nandrolone gets reduced into dihydronandrolone (DHN) instead, which binds the receptor weaker, not stronger. In tissue with high 5-alpha reductase activity, like the prostate, that flips the usual script: the reduction step turns a 19-nor down instead of up.

What the missing methyl group does not remove is affinity for the progesterone receptor. Nandrolone binds PR several times harder than testosterone does, though its potency there still sits well below progesterone itself. That’s the hook for the rest of this article: strip the C19 methyl, and you trade an estrogen problem for a progesterone problem.

Legal Status and Detection, Before Anything Else

Nandrolone is a Schedule III controlled substance under the Anabolic Steroids Control Act of 1990, expanded under the 2004 Act. Possessing it without a prescription is a federal crime, and where it is prescribed, it’s for a narrow list of approved uses, not muscle building.

Trenbolone has no FDA approval for humans, full stop. It exists commercially as a cattle implant (Finaplix and related products), built to add lean mass to livestock before slaughter, and no drug company has ever run it through a human Phase 1 trial. Anything sold as injectable trenbolone for a person is compounded outside any regulatory framework, with no guarantee the vial matches the label.

Both get caught the same way. WADA’s detection method targets 19-norandrosterone (19-NA), nandrolone’s shared urinary metabolite, with a reporting threshold of 2 ng/mL in both sexes (lowered from 5 ng/mL for women in 2004, once testing confirmed the body can produce a small amount on its own). Between 2 and 10 ng/mL isn’t automatic; the lab runs a carbon isotope ratio test to prove the metabolite came from outside the body. Nandrolone esters can still register for weeks past the last injection, longer than most oral compounds clear.

Nandrolone’s Progesterone Problem: The “Deca Dick” Mechanism

The mechanism behind the reputation runs through a specific chain, and it starts in the brain.

Progesterone receptors sit in the hypothalamus, and activating them suppresses dopaminergic tone. Dopamine normally keeps prolactin in check through a dopamine-mediated inhibitory signal from the pituitary. Turn that signal down and prolactin climbs, even with estradiol nowhere near the range that would normally explain it.

Elevated prolactin then does 2 separate jobs on the way to erectile dysfunction, and this is the part most explanations skip. The first: prolactin suppresses GnRH, which drops LH, which drops testicular testosterone output. The second runs independent of testosterone entirely. A urology review lays out mechanisms unrelated to androgen levels that still produce sexual dysfunction, and bench research found prolactin directly suppresses the PI3K-Akt-eNOS signaling pathway in penile tissue, the same nitric oxide pathway erectile function depends on. That’s the honest answer to why a guy on deca can have solid total testosterone and still lose function: the prolactin pathway doesn’t need low T to do its damage.

This also separates 19-nor progesterone activity from ordinary high-estrogen sides. Raise estradiol on a testosterone-only cycle and you get water retention and mood swings. Raise progesterone activity on a nandrolone cycle and you get a prolactin problem on top of whatever your estrogen is doing, through a separate receptor entirely.

Law 4, Self-Regulating Systems: Why 19-Nor Recovery Drags

Every axis in the body fights to hold its baseline, and the HPTA is one of the most stubborn examples. Push it down hard enough and the feedback loop pushes back the moment you stop pushing, which is the entire logic behind PCT. What 19-nors do differently is suppress that axis through 2 levers instead of 1.

The androgenic lever is familiar: exogenous androgen tells the hypothalamus testosterone is already high, GnRH pulses slow, LH and FSH drop, the testes stop producing. Trial data on nandrolone decanoate at 100 mg a week for 6 weeks measured endogenous testosterone production suppressed 57%; at 300 mg a week suppression reached 70%, comparable to what testosterone itself does at similar doses.

Lever 2 is the progestogenic one, and it doesn’t show up on a suppression chart the same way. Progesterone receptor activation adds its own antigonadotropic signal on top of the androgenic one, working through a different part of the same feedback loop. 2 separate inputs converging on the same axis is the same additive logic behind Law 5, independent receptor stacking, except here it’s working against you instead of for you. That’s the mechanistic reason recovery off a 19-nor-containing cycle tends to run slower and messier than an equivalent testosterone-only cycle: you’re un-suppressing 2 levers instead of 1, and they don’t necessarily let go on the same timeline.

Trenbolone: The Potent One With No Human Trials Behind It

Trenbolone binds the androgen receptor roughly 3 times as hard as testosterone, with affinity in the same range as DHT itself. That single number is why trenbolone has the reputation it has, and it’s also the reason to be careful about what “we know” actually means here.

Every trenbolone number people cite for humans, recovery time, cardiovascular strain, lipid impact, traces back to cattle growth studies (the reason Finaplix was built), in vitro androgen receptor binding assays, and observational bloodwork from people running it outside any research protocol, because no human clinical trial exists. Those sources can tell you trenbolone is a potent androgen receptor ligand. None of them can tell you what a controlled human dose-response curve looks like, because that study has never been run and, given its legal status, isn’t likely to be. That’s a real evidence gap, and it belongs in the first paragraph anyone writes about trenbolone.

Nandrolone vs Trenbolone: Same Family, Different Math

Both are 19-nors. Both skip aromatization almost entirely. That’s where the similarity ends. Nandrolone carries the progesterone receptor activity above, backed by real human trial data from HIV and AIDS wasting populations. Trenbolone binds the androgen receptor harder and carries no comparable data of any kind. If nandrolone’s problem is a second receptor doing damage nobody budgeted for, trenbolone’s problem is that almost nothing about its human use has been measured at all.

What 19-Nors Do to Your Lipids

This is the one place nandrolone comes out better than its reputation. A controlled 6-week trial running nandrolone decanoate at 100 mg a week in 24 subjects found no significant change in HDL, LDL, total cholesterol, or triglycerides, real counter-evidence against the blanket “steroids tank your HDL” line you’ll hear everywhere. The honest caveat: 6 weeks at a moderate injectable dose is nowhere near a multi-month cycle at higher doses, and the oral 17-alkylated compounds, different chemistry, different first-pass liver exposure, are the ones behind the roughly 50% HDL crashes that get cited most. Injectable esters like nandrolone and trenbolone acetate don’t carry that same liver burden. That doesn’t make lipids a non-issue; it means the mechanism doing the damage on a 19-nor cycle usually isn’t the one doing the damage on an oral compound, and your panel should reflect which one you’re actually running.

What I Watch on Bloodwork

This section stays testimony: what’s on my own panel and why. Take it to your own doctor rather than a dosing chart.

Prolactin first, for the reasons above. Estradiol second, because low estrogen from minimal aromatization isn’t automatically a win; it still matters for joints, lipids, and libido, and a 19-nor cycle can push it too low. Lipids, full panel, because the mechanism differs by ester and by dose and one number won’t tell you which problem you have. Hematocrit, because androgen-driven red cell production doesn’t care which class of androgen is driving it. LH and FSH, because that’s the only honest way to track whether the HPTA is actually coming back or just quiet for now.

Interesting Perspectives

The progesterone angle explains something the internet usually frames as mysterious: why 2 guys with identical estradiol numbers on a deca cycle can have completely different sexual side effect profiles. Estradiol isn’t the variable doing the damage there. Prolactin and individual progesterone receptor sensitivity are, and almost nobody tests for either one until symptoms force the question.

The trenbolone evidence gap cuts a different way than people assume. The usual framing is “nobody’s proven it’s dangerous in humans.” The more accurate framing is nobody’s proven anything about it in humans, danger or benefit, at a controlled dose. Absence of a trial is not a safety signal in either direction. It’s a missing dataset, and every claim built on it, including the ones defending it, is standing on cattle data and case reports.

Who This Applies To

This is educational chemistry for people already using 19-nor compounds or deciding whether to, and for anyone whose bloodwork flagged an unexplained prolactin or estradiol pattern, written for the actual mechanism instead of forum shorthand. If PCT planning around a 19-nor cycle is part of your thinking, liver load still belongs in that conversation; Enhanced Labs’ TUDCA is the liver-support product I’d point you to for that piece specifically (disclosure: I earn a commission through that link).

Recovery Timeline: What Suppression and Recovery Data Show

Timeframe What the data and reported patterns show
During use Endogenous testosterone production measured suppressed 57% to 70% at 100 to 300 mg/week nandrolone decanoate in controlled dosing. Prolactin can rise independent of estradiol.
First weeks off LH and FSH typically remain suppressed; nandrolone esters can still register on a 19-NA urine test for weeks after the last injection.
Following months HPTA recovery on a 19-nor-containing cycle is widely reported as slower than testosterone-only cycles, consistent with 2 separate suppressive pathways (androgenic and progestogenic) needing to resolve rather than 1.
Longer term Prolactin and libido symptoms tied to progesterone receptor activity typically resolve once the compound clears and dopaminergic tone normalizes; LH/FSH and total testosterone are the labs that confirm the axis, not symptoms alone.

Where 19-Nors Sit Next to Other Pathways

Compound / pathway What it hits Why it’s relevant here
Nandrolone (19-nor, progesterone receptor) Androgen receptor + progesterone receptor The second receptor is the whole prolactin story above
Trenbolone (19-nor, no PR data in humans) Androgen receptor, ~3x testosterone’s affinity No human trial exists to define its suppression or lipid math
Prolactin / dopamine axis D2 receptor tone in the hypothalamus The pathway a 19-nor cycle needs watched separately from estrogen
HPTA (LH/FSH/GnRH) Androgen + progestogenic negative feedback 2 suppressive inputs converge here on a 19-nor cycle

References

  1. Reel JR, Humphrey RR, Shih YH, Windsor BL, Sakowski R, Creger PL, Edgren RA. “Competitive progesterone antagonists: receptor binding and biologic activity of testosterone and 19-nortestosterone derivatives.” Fertility and Sterility. 1979;31(5):552-561. DOI: 10.1016/s0015-0282(16)44003-3 (PMID: 446780)
  2. Bauer ER, Daxenberger A, Petri T, Sauerwein H, Meyer HH. “Characterisation of the affinity of different anabolics and synthetic hormones to the human androgen receptor, human sex hormone binding globulin and to the bovine progestin receptor.” APMIS. 2000;108(12):838-846. DOI: 10.1111/j.1600-0463.2000.tb00007.x (PMID: 11252818)
  3. Yarrow JF, McCoy SC, Borst SE. “Tissue selectivity and potential clinical applications of trenbolone (17β-hydroxyestra-4,9,11-trien-3-one): a potent anabolic steroid with reduced androgenic and estrogenic activity.” Steroids. 2010;75(6):377-389. DOI: 10.1016/j.steroids.2010.01.019 (PMID: 20138077)
  4. Gold J, Batterham MJ, Rekers H, et al. “Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.” HIV Medicine. 2006;7(3):146-155. PMID: 16494628
  5. Sardar P, Jha A, Roy D, Majumdar U, Guha P, Roy S, Banerjee R, Banerjee AK, Bandyopadhyay D. “Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial.” HIV Clinical Trials. 2010;11(4):220-229. DOI: 10.1310/hct1104-220 (PMID: 20974577)
  6. Zeitlin SI, Rajfer J. “Hyperprolactinemia and erectile dysfunction.” Reviews in Urology. 2000;2(1):39-42. PMID: 16985734
  7. Glazer G, Suchman AL. “Lack of demonstrated effect of nandrolone on serum lipids.” Metabolism. 1994;43(2):204-210. DOI: 10.1016/0026-0495(94)90246-1 (PMID: 8121303)
  8. World Anti-Doping Agency. Technical Document TD2010NA, “Harmonization of Analysis and Reporting of 19-Norsteroids Related to Nandrolone.” Effective September 1, 2010. wada-ama.org (Regulatory document, no PMID)
  9. US Drug Enforcement Administration. “Implementation of the Anabolic Steroid Control Act of 2004.” Federal Register. 70 FR 74653, December 16, 2005. federalregister.gov (Regulatory document, no PMID)

Frequently Asked Questions

What is a 19-nor steroid?

A 19-nor steroid is a testosterone derivative missing the carbon-19 methyl group. Nandrolone and trenbolone are the 2 most common examples, and both aromatize to estrogen far less than testosterone does because of that missing carbon.

Are 19-nor steroids like nandrolone legal to use?

Nandrolone is a Schedule III controlled substance in the US under the Anabolic Steroid Control Act, legal only with a prescription for a narrow set of approved medical uses. Trenbolone has no approved human use anywhere; it is manufactured and sold only as a veterinary cattle implant.

What causes “deca dick” and is it really about progesterone?

The leading mechanism is nandrolone’s activity at the progesterone receptor, which suppresses dopamine tone and raises prolactin. Elevated prolactin then lowers LH-driven testosterone output and separately impairs the nitric oxide pathway in penile tissue, which is why the problem can show up with normal estradiol and testosterone numbers.

How do nandrolone and trenbolone compare?

Both barely aromatize. Nandrolone carries real progesterone receptor activity and has actual human trial data, mostly from HIV and AIDS wasting research. Trenbolone binds the androgen receptor harder and has never been studied in a human clinical trial of any kind.

How is nandrolone use detected on a drug test?

WADA-accredited labs test urine for 19-norandrosterone, nandrolone’s primary metabolite, with a 2 ng/mL reporting threshold in both sexes. Results between 2 and 10 ng/mL require a carbon isotope ratio test to rule out the small amount the body can produce on its own before a violation is confirmed.


This article covers the published research on 19-nor pharmacology and my own bloodwork-monitoring practice. It is not medical advice or an instruction to obtain or use a controlled substance or an unapproved veterinary compound. Nandrolone is prescription-only; trenbolone has no human medical use anywhere.

More in the testosterone hub.